TY - JOUR T1 - Epigenetic clock and methylation studies in dogs JF - bioRxiv DO - 10.1101/2021.03.30.437604 SP - 2021.03.30.437604 AU - Steve Horvath AU - Ake T. Lu AU - Amin Haghani AU - Joseph A. Zoller AU - Robert T. Brooke AU - Ken Raj AU - Jocelyn Plassais AU - Andrew N. Hogan AU - Elaine A. Ostrander Y1 - 2021/01/01 UR - http://biorxiv.org/content/early/2021/03/30/2021.03.30.437604.abstract N2 - DNA methylation profiles have been used to develop biomarkers of aging known as epigenetic clocks, which predict chronological age with remarkable accuracy and show promise for inferring health status as an indicator of biological age. Epigenetic clocks were first built to monitor human aging but the principles underpinning them appear to be evolutionarily conserved, as they have now been successfully developed for over 120 mammalian species. Here we describe reliable and highly accurate epigenetic clocks shown to apply to 51 domestic dog breeds. The methylation profiles were generated using a custom array with DNA sequences that are conserved across all mammalian species (HorvathMammalMethylChip40). Canine epigenetic clocks were constructed to estimate age and also predict mortality risk by estimating average time-to-death. We also present two highly accurate human-dog dual species epigenetic clocks (R=0.97), which may facilitate the ready translation from canine to human use (or vice versa) of anti-aging treatments being developed for longevity and preventive medicine. Finally, epigenome-wide association studies herein reveal individual methylation sites that may underlie the inverse relationship between breed weight and lifespan. Overall, we describe robust biomarkers to measure aging and potentially health status in canines.Competing Interest StatementSH is a founder of the non-profit Epigenetic Clock Development Foundation which plans to license several patents from his employer UC Regents. These patents list SH as inventor. Robert T. Brooke is the Executive Director of the Epigenetic Clock Development Foundation. The other authors declare no conflicts of interest. ER -